WORLD
FDA Pulls Authorization for GSK-Vir's COVID Therapy as BA.2 Cases Rise - Latest Tweet by Reuters
The latest Tweet by Reuters states, 'FDA pulls authorization for GSK-Vir's COVID therapy as BA.2 cases rise ...'
FDA pulls authorization for GSK-Vir's COVID therapy as BA.2 cases rise https://t.co/nI189GcFQu pic.twitter.com/vB0ybgX0Us— Reuters (@Reuters) April 6, 2022
(The above story first appeared on LatestLY on Apr 06, 2022 08:09 AM IST. For more news and updates on politics, world, sports, entertainment and lifestyle, log on to our website latestly.com).
